Close Menu

Biocept

Biocept announced the hiring of Amy McNeal as its new senior director of managed care and reimbursement strategies. Biocept is a molecular diagnostics firm specializing in analysis of biomarkers from circulating tumor cells and DNA.

The headline has been corrected to state that Biocept's first quarter revenues decreased, not increased, 20 percent.
NEW YORK (GenomeWeb) – Newly publicly traded firm Biocept yesterday reported a 20 percent drop year over year in its first quarter revenues.

NEW YORK (GenomeWeb) – Biocept has entered into a $10 million loan and security agreement with Oxford Finance, the San Diego-based oncology diagnostics firm said in a US Securities and Exchange document on Tuesday.

UK's CHMP Grants Positive Review of MEK Inhibitor Melanoma Drug Mekinist
The UK's Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission grant marketing authorization to GlaxoSmithKline's Mekinist (trametinib).

NEW YORK (GenomeWeb News) – Oncology diagnostics company Biocept said on Friday that its revenues for 2013 increased 23 percent year over year.

NEW YORK (GenomeWeb News) – Biocept said after the close of the market on Monday that it has closed its initial public offering, raising $19 million in gross proceeds.

NEW YORK (GenomeWeb News) – Biocept today went public as shares of its common stock began trading at $10, the low end of an anticipated price range on its initial public offering.

Becton Dickinson disclosed during its fiscal fourth quarter and full-year earnings call several changes to its executive leadership.

NEW YORK (GenomeWeb News) – Biocept today set the price range on its planned initial public offering, saying it expects to price its shares between $10 and $12.

NEW YORK (GenomeWeb News) – Circulating tumor cell-based diagnostics firm Biocept on Monday filed with US regulators to go public with an initial public offering intended to raise up to $24.25 million.

Pages

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.